ReviewPediatric radiology2026
Imaging and characterization of pulmonary nodules in children with solid tumors: what makes a pulmonary nodule a metastasis?
Review in Pediatric radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Evaluating pulmonary nodules in children requires balancing reliable detection with minimizing risks, particularly radiation exposure. Chest radiography serves as a useful first-line modality, but computed tomography (CT) remains essential despite concerns about radiation dose and motion artifacts. Pulmonary nodules are frequently identified even in otherwise healthy children, and distinguishing benign lesions from metastatic disease in those with solid tumors continues to be clinically challenging, with no universally accepted diagnostic criteria. This article aims, firstly, to provide clues for defining pulmonary nodules with typically or definitively benign characteristics and, secondly, to underscore an overview of current imaging criteria per tumor group and the clinical implication of the presence of pulmonary nodules on event-free survival and overall survival. Accurate differentiation is crucial because it directly influences staging, management, and prognosis. Several issues like interobserver variability in detection/characterization and the inherent difficulty to finally characterize the nodule's etiology are still to be resolved, but the development of new techniques (magnetic resonance imaging (MRI), etc.) challenges these uncertainties.
Indexed as
Identifiers
42101476What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.